MultiMedRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.9/10
Best for: compounded semaglutide or tirzepatide from a clinic that says it compounds in its own pharmacy
MultiMedRx falls below our bar on disclosure. Its compounded semaglutide costs $199 a month, the same as the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $199/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
MultiMedRx is a Newport Beach, California telehealth clinic that now sells compounded semaglutide and tirzepatide it says it compounds in its own licensed pharmacy. Regular prices are $199 and $299 per 4-week cycle, with first-month offers of $139 and $179 that include the visit, the prescription and shipping. Plans run month to month and cancel by email. It also prescribes metformin, testosterone and HRT, and shows a LegitScript seal.
Is MultiMedRx legit?
Yes. MultiMedRx is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 5.9/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a MultiMedRx promo or coupon code?
MultiMedRx has no coupon code to enter. New patients are currently quoted $139 for the first month, then $199 a month, and the discount applies on its own. Coupon sites advertising a "MultiMedRx promo code" are not a source we can vouch for.
See how MultiMedRx compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to MultiMedRx
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Editorial score · methodology
MultiMedRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How MultiMedRx scores
Six columns, each one computed from something MultiMedRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.0/10$199/month is exactly the median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
2.5/10No price appears until the medical intake is finished. A live video visit is required, which is slower but the more careful intake.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on MultiMedRx
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for MultiMedRx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with MultiMedRx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1MultiMedRx shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2The intake requires a live video visit with a clinician before a first prescription, which takes longer than a written form and is the more careful route.
- 3Ask MultiMedRx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 4The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that MultiMedRx serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting MultiMedRx
- Phone
- 800-787-9659
Cancelling MultiMedRx
Taken from the terms MultiMedRx publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- 4-week cycles, billed every 4 weeks; longer contracts optional
- Refund policy
- Upfront visit fees are refunded if you are found ineligible; returns only on unopened products, never refrigerated items
Medications MultiMedRx lists
MultiMedRx lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
"$139 Intro offer — first month (regularly $199)". Includes provider evaluation, prescription, 4 weeks of medication and shipping. A footnote says pre-paid totals are required to receive the offer.
"$179 Intro offer — first month (regularly $299)". Includes provider evaluation, prescription, 4 weeks of medication and shipping.
Check the price yourself before you pay
Every figure here comes from MultiMedRx's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, exactly the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $299 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to MultiMedRx
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What MultiMedRx charges
The figure MultiMedRx leads with is $139, and it is a first-month rate. From month two the price is $199/month, which is the number to plan around. There is nothing wrong with an introductory offer; it just is not the price of staying on the medication.
- Compounded semaglutide: $139 first month, then $199/month
- Compounded tirzepatide: $179 first month, then $299/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so MultiMedRx's $199 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare MultiMedRx's cancellation terms with other sellers' cancellation and refund policies.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What MultiMedRx dispenses
MultiMedRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
Safety and disclosure
Before you start an intake, ask MultiMedRx which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. We found no FDA warning letters issued to MultiMedRx. The pharmacy question matters most here because the medication is compounded. If MultiMedRx will not name the pharmacy, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether MultiMedRx bills your plan before you start.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
Our read
MultiMedRx is a cheap way to start and an ordinary way to continue. Use the $139 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $199/month before you let it renew twice. The catch is disclosure, which is why MultiMedRx scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you. Belle Health is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
MultiMedRx falls below our bar on disclosure. Its compounded semaglutide costs $199 a month, the same as the $199 median among the sellers we compare.
Before you pay MultiMedRx
Starting at $199 a month. Check today's price, then start the intake.
Where MultiMedRx is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to MultiMedRx sets more sellers in the same category beside MultiMedRx on price, states and what the price includes.
Frequently Asked Questions
How to check MultiMedRx yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MultiMedRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See MultiMedRx's current pricing
Plans start at $139 a month. Whether you qualify is a clinician's decision, made after your intake.